Clinical Trial Update: The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Andrographis Paniculata for palliative management in advanced esophageal squamous cell carcinoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Andrographis paniculata (Andrographis paniculata)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Squamous Cell Carcinoma of Esophagus | Phase 3 | Status: COMPLETED